ETHOSUXIMIDE is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Pai Holdings, Llc. The primary component is Ethosuximide.
| Product ID | 0121-0670_0ee6fdf9-bfba-4f73-a0b8-76d7ac9ada7b |
| NDC | 0121-0670 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ETHOSUXIMIDE |
| Generic Name | Ethosuximide |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2000-11-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA040253 |
| Labeler Name | PAI Holdings, LLC |
| Substance Name | ETHOSUXIMIDE |
| Active Ingredient Strength | 250 mg/5mL |
| Pharm Classes | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2000-11-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA040253 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-11-22 |
| Ingredient | Strength |
|---|---|
| ETHOSUXIMIDE | 250 mg/5mL |
| SPL SET ID: | 8a5cc930-0b36-48a8-9ad0-de633b208742 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-9660 | Ethosuximide | Ethosuximide |
| 0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 23155-532 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 42806-711 | Ethosuximide | Ethosuximide |
| 46672-641 | ethosuximide | ethosuximide |
| 59762-2250 | Ethosuximide | Ethosuximide |
| 59762-2350 | Ethosuximide | Ethosuximide |
| 61748-024 | Ethosuximide | Ethosuximide |
| 61748-025 | Ethosuximide | Ethosuximide |
| 63629-8005 | Ethosuximide | Ethosuximide |
| 64380-878 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 68382-443 | ethosuximide | ethosuximide |
| 69387-108 | Ethosuximide | Ethosuximide |
| 69452-152 | Ethosuximide | Ethosuximide |
| 71335-1763 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 0071-0237 | Zarontin | Ethosuximide |
| 0071-2418 | Zarontin | Ethosuximide |